Skip to main content

Fecal incontinence: challenges in electrodiagnosis and rehabilitation

Abstract

Background

Pelvic floor disorders are a common, yet debatable medical challenge. The management of fecal incontinence (FI) has always been a puzzle as it is a multifactorial problem that needs a skilled specialized teamwork.

Main body of abstract

FI has complex etiology including altered rectal sensibility, dysfunction of the pelvic floor muscles, and damage to the anal sphincter complex. The most valuable tests for the evaluation of FI are anorectal manometry, endoanal ultrasound, MRI with or without defecography, and neurophysiological studies. Neurophysiological tests of the pelvic floor muscles represent a valid method for studying the functional integrity of neural pathways, localizing a pathological process, and possibly revealing its mechanism and severity. These tests include assessment of conduction of the pudendal nerve, electromyography (EMG) of the sphincter as well as pelvic floor muscles, sacral reflexes, somatosensory-/motor-evoked responses, and perineal sympathetic skin response. Different approaches are available for the treatment of FI. These include conservative measures such as lifestyle and dietary modifications, medications, and pelvic floor rehabilitation which are considered the preferred lines to avoid the risk of interventions. However, more invasive approaches as the use of perianal injectable bulking agents, sacral nerve stimulation, or surgery are also present.

Conclusion

Finally, management of FI is a true challenge that needs multidisciplinary approach. Integrated diagnostic work-up between the related subspecialities, as well as tailoring the management plan according to each case, would help to reach best outcome.

Background

Fecal incontinence (FI) is defined as the involuntary passage of fecal matter through anus or the inability to control the discharge of bowel contents. Its severity can range from an involuntary passage of flatus to complete evacuation of fecal matter. Depending on the severity of the disease, it has a significant impact on patient’s quality of life [1]. The prevalence of FI is difficult to estimate because it is underreported due to social stigma. The overall reported prevalence ranges from 2 to 21% with a median of 7.7%. There is significant variation depending on age. The prevalence of FI is reported as 7% in women younger than 30 years which rises to 22% in their 7th decades. In geriatric patients, the prevalence is reported as high as 25 to 35% of nursing home residents and 10 to 25% of hospitalized patients. In fact, FI is considered the second leading cause of nursing home placement in the geriatric population [2, 3]. The mechanism of fecal continence relies on the coordinated function of the nervous system, gastrointestinal tract, anal sphincter, and pelvic floor musculature (Fig. 1). Stool is often transferred into the rectum by colonic high-amplitude-propagated contractions, which often occur after awakening or meals [4]. 

Fig. 1
figure 1

Pelvic view of the levator ani demonstrating its four main components: puborectalis, pubococcygeus, iliococcygeus, and coccygeus [5]

Main text

As the fecal mass presents to the rectum, this causes distension. The sensation of rectal distension is transmitted by the parasympathetic nerves (S2–S4) which induces inhibition of the rectoanal inhibitory reflex and activation of the rectoanal contractile reflex. This causes rectal contraction and anal sphincter relaxation, facilitating evacuation. The pelvic floor, particularly the puborectalis, also generally relaxes during defecation as shown in Fig. 2. Simultaneous assessments of intrarectal pressures and pelvic floor activity reveal that increased intrarectal pressure and anal relaxation are required for normal defecation [5].

Fig. 2
figure 2

Key components of the physiology of the defecatory system and their action [6]

FI is a multifactorial problem including altered rectal sensibility, dysfunction of the pelvic floor, and damage to the anal sphincter complex. Patients with FI have an unintentional loss of liquid or solid stool. The etiology of the condition includes central or autonomic nervous system insults as cerebrovascular strokes, multiple sclerosis and spinal cord injury in addition to inflammatory bowel disease, irritable bowel syndrome, diabetes mellitus, previous anal surgery, and vaginal delivery. FI can also result from enlarged skin tags, poor hygiene, hemorrhoids, rectal prolapse, and perianal fistula. Other common causes include the use of laxatives and parasitic infections [1]. In children, FI is either due to functional or organic causes. The functional causes include constipation-associated FI and functional non-retentive FI, while organic causes include repaired anorectal malformations, post-surgical Hirschsprung disease, spinal dysraphism, spinal cord trauma/tumors, cerebral palsy, and myopathies affecting the pelvic floor and external anal sphincter [7]. Diagnostic testing is guided by whether incontinence is related to stool consistency or not. If diarrhea is suspected as a primary reason for incontinence, stool analysis for infection, osmolality, fat content, and pancreatic insufficiency is recommended together with evaluation of diabetes and thyroid disorder, evaluation for bacterial overgrowth, and lactose/fructose intolerance and colonoscopy to evaluate mucosal disease (IBD/colitis), mass, ulcer, and stricture. If incontinence is without any diarrhea, more specific testing should be conducted. The most valuable tests for the evaluation of FI are anorectal manometry, endoanal ultrasound, MRI with or without defecography, and neurophysiological studies [8, 9]. Anophysiology studies attempt to correlate the subjective complaints and clinical exam findings with objective parameters. However, the predictability of all tests remains a challenge [10]. Due to the limited usefulness of clinical examinations and anorectal manometric and imaging studies, clinical neurophysiologic methods continue to play an important role in determining whether anorectal disorders as FI have a neurogenic etiology [11].

Electrodiagnosis of pelvic floor and sphincters

The impetus to develop electrophysiological techniques for the purpose of investigating sphincter function in order to determine the cause of FI came from the work of Beersiek and his colleagues in 1979 [12]. They identified histological changes in the anal sphincter, showing evidence of denervation of the muscle. The standard electrodiagnostic tests used elsewhere in the body were somehow adapted for studying the external anal sphincter (EAS) and pelvic floor muscles. These tests have offered a comprehensive knowledge of the pathophysiology of incontinence and pelvic floor disorders [13]. Electrodiagnostic tests of the pelvic floor muscles represent a valid method for studying the functional integrity of neural pathways, localizing a pathological process, and possibly revealing its mechanism and severity [14,15,16].

Neurophysiological assessment of the pelvic floor includes assessment of conduction of the pudendal nerve, electromyography (EMG) of the sphincter as well as pelvic floor muscles, sacral reflexes, somatosensory/motor evoked responses, and perineal sympathetic skin response.

Pudendal nerve terminal motor latency (PNTML)

Weakness of the external anal sphincter due to pudendal nerve damage may occur in 2 ways: a direct stretch-induced injury as during vaginal delivery and chronic straining. In addition, damage to the pelvic nerves causing perineal descent which in turn leads to pudendal nerve stretch, thus causing abnormal pudendal nerve motor latency [12]. Pudendal nerve conduction studies (NCS) are the most commonly reported electrodiagnostic (EDX) tests done on the pelvic floor. A pudendal electrode, also known commonly as “St. Mark’s electrode,” (Fig. 3) consists of a stimulating cathode and anode and two recording electrodes, which can be attached to a gloved index finger. The stimulating electrodes are positioned on the tip of the index finger, while the recording electrodes are placed at the base. Then, the pudendal nerve is stimulated at the ischial spine level (Fig. 4). If stimulation is applied transrectally, the recording electrodes are located at the external anal sphincter. Since PNTML is evaluating conduction speed, it is considered an assessment for the faster conduction nervous fibers, and accordingly, it is not a good guide about muscular denervation [17].

Fig. 3
figure 3

a Pudendal electrode. b A bipolar-stimulating electrode is mounted on the tip of the gloved index finger, which is inserted into the rectum. c Recording electrodes located 3 cm proximally at the base of the finger pick up the contraction response of the anal sphincter. d Application of pudendal electrode transrectally [10]

Fig. 4
figure 4

Position of needle insertion in external anal sphincter EMG [18]

In women, it is preferable to stimulate the pudendal nerve using a transvaginal approach with surface electrodes placed over the external anal sphincter (EAS) at the 3 and 9 o’clock positions with the patient in dorsal lithotomy or left lateral position. Older age, more vaginal deliveries, and a wide genital hiatus were associated with longer pudendal and perineal nerve terminal motor latencies. Normative data for pudendal nerve studies are illustrated in Table 1.

Table 1 Normative pudendal nerve conduction values [6]

Pudendal and perineal nerve conduction studies have established a link between pudendal neuropathy and fecal incontinence. Prolongation of PNTML suggests pudendal neuropathy, and bilateral, not unilateral, neuropathy has been associated with diminished sphincter function and higher incontinence scores [19, 20]. The test of pudendal nerve has been found to be relatively insensitive to axonal lesion, because amplitude of response is variable between control subjects (particularly due to technical reasons), and conduction may remain normal in partial lesions [21]. The pudendal nerve study assesses the large, myelinated, fastest-conducting fibers in a nerve, and hence, loss of the slower-conducting fibers may be missed. PNTML has been used in different clinical conditions, but its clinical value has been questioned because the reproducibility, sensitivity, and specificity are still uncertain. It should not be used in isolation from other EDX tests when evaluating pelvic floor injuries. Generally, EMG follows NCSs since EMG is more sensitive for detecting neuropathic injury [22].

Electromyography (EMG)

Electromyography (EMG) is the recording and analysis of electrical activity from striated muscles and can be used to distinguish between normal, denervated, and reinnervated muscle. EMG aims at analyzing the motor units by means of either painless but imprecise surface electrodes or through precise but painful needle electrodes (Fig. 4). EMG may also play a role in confirming paradoxical puborectalis contraction in patients with obstructed defecation [23]. Voluntary electrical activity is recorded as motor unit action potentials (MUAP), which represent the summation of activity from multiple motor units. Insertional activity is the electrical activity detected by the concentric needle electrode as it passes through the muscle at rest (Fig. 5). When the electrode is in healthy muscle, the insertional activity will return to baseline in 300 ms. Decreased insertional activity indicates that the electrode is not in muscle, or that the muscle has undergone severe atrophy and has been replaced by electrically inactive tissue as in cases of postsurgical fibrosis [23]. Spontaneous activity is persistent electrical activity after the needle is inserted and results from marked membrane instability of the muscle or neuron innervating it. Unlike most skeletal muscles, which are electrically silent at rest, the pelvic floor muscles have baseline tonic electrical activity assessed and named as resting tone, making it more difficult to detect spontaneous activity. The most common form of spontaneous activity in skeletal muscles is the presence of positive sharp waves or fibrillation potentials [15]. The commonest type of abnormal spontaneous activity reported in pelvic floor muscles is complex repetitive discharges (CRD). Even though CRDs are nonspecific findings, their presence usually suggests ongoing chronic denervation and reinnervation in the muscle [21].

Fig. 5
figure 5

Needle electrode recording in EAS for rest, squeeze, strain, and cough [24]

Motor unit recruitment refers to the pattern in which motor units are recruited by the spinal cord. Muscle increases force by increasing the frequency and number of individual firing motor units. Sphincter muscles’ EMG recordings are performed at rest and during squeezing, coughing, and straining that simulates rectal evacuation. Therefore, as voluntary effort is increased, an increased number and frequency of MUAPs should be seen (tested and analyzed as minimum squeeze power). At maximum effort (usually named maximum squeeze power), so many motor units are firing that individual MUAPs cannot be distinguished, resulting in an interference pattern [25]. Since sphincter MUAPs are smaller than other striated muscles, it is important to know the commonly used settings. Amplifier gain is typically reduced to 50 µV, and filter settings are set at 10 Hz and 10 kHz with a sweep speed of 10 ms/div [23]. The normative data for mean values of EAS motor units action potentials are shown in Table 2.

Table 2 Normative data for mean values of individual MUAP parameters [26]

Quantitative EMG (QEMG) of the EAS with automated analysis of MUAPs is the most widely used method in clinical practice. A set of three MUAP parameters with the highest predictive power for neuropathic signs is proposed (i.e., area, duration and number of turns) [16].

In multiple system atrophy (MSA) studies, MUP duration together with percentage of polyphasic MUPs is the two main electromyographic parameters considered. EMG of the EAS muscle, especially use of the single MUP technique with inclusion of late components for measuring MUP duration, shows neurogenic MUP changes in MSA patients compared with controls, with an abnormality rate of more than 70% [16].

Neurophysiologic tests for children suffering from FI following transanal endo rectal pull-through operation (for Hirschsprung’s disease) showed a statistically significant lower resting tone, a significant prolongation of MUAP duration with higher mean of polyphasicity when compared to controls [27]. Comparing male and female patients with FI suggests that female patients tend to have worse sphincter function than men. Both groups had similar EMG alterations, suggesting a common neurogenic injury as etiology [28]. Prior to the more widespread use of anal ultrasound, investigators would utilize EMG to “map” the location of functioning anal sphincter muscle.

Sacral reflex testing

Reflex contractions of pelvic floor muscles occur after stimulation of certain pelvic floor sites resulting in sacral reflexes. Those reflexes are mediated through afferent and efferent connections between sacral spinal segments and the muscles through the pudendal nerve. Sacral reflexes are altered in few patients with suprasacral lesions, and they are not useful for evaluating spinal cord damage. They can be recordable following mechanical or electrical stimulations over the penis while recording directly from the bulbocavernosus muscle using a concentric or monopolar needle. Different forms of sacral reflexes have been described, and the ones chiefly employed in pelvic floor evaluation are the urethral-anal reflex, the bladder-anal reflex, and the clitoral/penile-anal reflex. Sacral reflex studies have a greater sensitivity than the clinical elicitation of the reflex [15]. Electrical stimulation over the penis/clitoris will elicit a monosynaptic reflex response (R1) at around 30 ms and a polysynaptic late response (R2) at around 60 ms. The R1 is a direct response and exhibits no habituation to repeated electrical stimulations. A prolonged latency or absent response is considered as abnormal. They are an important tool to evaluate the integrity of sensory and motor components of the pudendal nerve [16]. There was a statistically significant higher mean latencies of sacral reflex in patients suffering from FI. The cutoff value of the pudendo-anal reflex was 40.88 ms [27]. Increased latency or non-elicitable responses are the most frequent abnormal findings. Needle EMG examination together with bulbocavernosus reflex study will increase the yield of detecting cauda equina and conus medullaris lesions to over 95% [16, 29].

Pudendal somatosensory-evoked potentials (pSEPs)

Unlike the basic sensory nerve conduction studies, the pelvic region sensory nerves are inaccessible for electrical stimulation. Hence, the nerve is stimulated peripherally while recording its response from the somatosensory cortex of the brain using surface scalp electrodes. The pudendal somatosensory-evoked potential study is a well-established test and the most commonly performed evoked potential study in the pelvic region [30]. Evaluation of pSEPs provides information about the integrity of the somatosensory afferent pathways from the pudendal nerve to the parietal cortex. Pudendal somatosensory-evoked potential is easily recorded using a similar technique to that which is used for recording the tibial-evoked potential but with stimuli applied to the dorsal nerve of the penis or clitoris. The response has a similar waveform and even latency to that of the tibial-evoked response—the slower conduction being due to the composition of the penile nerve being sensory only and lacking the fast-conducting muscle afferent fibers of the tibial nerve. Pudendal nerve cortical somatosensory-evoked potentials are used to assess suprasegmental pathways. It was mentioned by Benson (1996) that measuring the pudenda-anal reflex and the pudendal-evoked potential allows examination of both segmental and suprasegmental neural pathways to the sacral cord [31].

Nevertheless, the pudendal SEPs have few limitations due to technical and anatomical factors. The cortical amplitudes are relatively lower than those recorded from mixed nerves as the posterior tibial nerve. This could be due to the absence of large diameter sensory fibers in the dorsal nerve of the penile/clitoris. Owing to the low cortical potentials, it is challenging to determine amplitude asymmetry. Pudendal responses are recorded mainly from S2 to S4. Hence, partial lesions affecting only some of the roots may be missed during studying pudendal SEP. Moreover, the faster unaffected dorsal root fibers convey the signals to the cortex with normal latency. Finally, the supramaximal stimulation on one side (especially at the penis base in males) may result in co-stimulation of the contralateral nerve. Due to these limitations, it may not be possible to provide a precise localization when lateralized sacral root injury is suspected which limits the clinical utility of recording pudendal SEPs [32]. Lately, the dermatomal somatosensory-evoked potentials (DSEP) measurement may assist in overcoming some of these limitations. Recording technique for DSEPs is similar to pudendal SEPs; however, individual dermatomes are stimulated rather a nerve branch of a sensory nerve [33].

Pudendal magnetic-evoked potentials (pMEPs)

Transcranial magnetic stimulation can be used to test the motor efferent to the pelvic floor muscles. Studies investigating the diagnostic role of pMEPs in patients with neurological disorders are sparse and heterogeneous. Some reported good reliability of pMEPs in discriminating patients with central nervous system disorders from healthy subjects. On the other hand, some healthy subjects may show absent response to cortical stimulation due to the difficulty of stimulating deep cortical structures, hence limiting the clinical value of this method [16].

Perineal sympathetic skin response (SSR)

Clinical neurophysiological investigations such as nerve conduction studies, electromyography, and evoked potential studies are helpful to assess somatic afferent and efferent nerve pathways. Sympathetic skin response test is helpful to assess sympathetic pathways [33]. The SSR is used to test sympathetic sudomotor activity by assessing conductance changes across the skin as a response to peripheral nerve electrical stimulation. It is mediated through myelinated somatosensory afferent fibers, a central autonomic network, and sympathetic cholinergic efferent fibers controlled by complex supraspinal signals. The distribution of eccrine glands is not uniform over the body, and their density is greatest over the palms and soles [34] and more thinly distributed over the thighs and back. SSR response recorded from the perineal skin is therefore of much smaller amplitude compared to palms and soles. Moreover, the responses are affected by a temperature, stimulus strength, habituation, and patient relaxation. Thus, the examiner should be aware of the physiological and environmental factors when interpreting the SSR. Due to the marked variability in SSR amplitude, just the presence of a clear response is sufficient to document a normal study [33]. Finally, no statistically significant difference in SSR data could be reported between patients with FI and controls in literature [27].

Pelvic floor rehabilitation

Different approaches are available for the treatment of FI. Conservative measures are usually considered the preferred first line of treatment. However, more invasive procedures are available on individual basis [35]. A stepwise approach to treatment is usually advocated to minimize injury to patients [36]. Pelvic floor rehabilitation (PFR) is a broad-spectrum entity that constitutes different techniques including bowel management education and retraining, EMG biofeedback-guided pelvic floor muscle training (PFMT), biofeedback therapy (BFT), the use of electrical stimulation, and manual myofascial release techniques. Biofeedback therapy is the broad general term referring to recording different biomechanical or physiological parameters with a feedback in the form of visual and/or auditory signals. EMG biofeedback implies recording muscles activity, and this is the most commonly used technique in pelvic floor dysfunction rehabilitation. This could be achieved using surface electrodes, intrarectal or intravaginal probes. Other types as manometry biofeedback are also used. These various rehabilitative techniques are usually used in combination to produce the maximum benefit for the patient. The principal aim of all forms of pelvic floor rehabilitation is to improve pelvic floor and anal sphincter muscle strength, tone, endurance, and coordination to achieve better function. PFR also works on increasing the patient’s awareness of their own muscles and improving rectal sensitivity allowing improved muscle function [37, 38].

Lifestyle and diet modifications

PFR lifestyle education and diet modifications incorporation in the management of patients with FI are of great importance [35]. These might include but not limited to instructions to optimize fluid intake and dietary adjustments [39]. Regulating dairy, gluten, and fiber contents in diet is a crucial component [40]. Fiber supplementation was found to significantly reduce the rate of FI with recommended daily supplementary fiber intake of 2–6 g per day [41, 42]. Behavior modifications include creating a scheduled time for bowel evacuation in a trial to limit incontinent episodes. Teaching the proper defecation posture to avoid straining, together with fecal urge suppression techniques, is also key measures [39, 43]. Weight reduction is typically encouraged, as obesity is a well-documented risk factor for the development of FI [44].

Medications

Some medications have been used in managing FI. Loperamide is a synthetic opioid which was found beneficial in reducing urgency FI. It works on inhibiting intestinal peristalsis, thus increasing oral-cecal transit time. It also increases resting anal sphincter tone, thus improving rectal perception and rectal compliance [45]. Anticholinergic medications, such as hyoscyamine, can help decrease postprandial leak if taken before meals. Also, amitriptyline has been shown to increase colon transit time by decreasing rectal contractions in patients with idiopathic FI [42]. Cholestyramine is helpful in patients with bile salt malabsorption. Low-dose clonidine, an α-adrenergic agent, also can be used to reduce rectal sensation and urgency [46, 47]. Phenylephrine gel applied directly to the sphincter was shown to increase internal anal sphincter (IAS) tone, possibly beneficial for patients with intact IAS but low-resting pressure [47, 48].

Pelvic floor muscle exercise training (PFMT)

PFMT typically consists of verbally guided instruction for pelvic floor and sphincter contractions (Kegel contractions) [49]. It was introduced for the treatment of FI in the 1970s [50]. Contractions could be done in various ways as maximal voluntary sustained sphincter contractions, submaximal sustained contractions, or fast-twitch or “quick-flick” contractions [51, 52]. It aims to improve muscle tone and sphincter strength, thus leading to an increased patient’s ability to delay defecation. Moreover, it has been hypothesized that training all core muscles would be more beneficial than merely focusing on the pelvic floor muscles alone [51]. A study showed that all patients who underwent pelvic floor exercises with either biofeedback with anal manometry, biofeedback with transanal ultrasound, or with feedback from digital examination all experienced highly significant improvements [53].

Biofeedback therapy

Biofeedback is defined primarily as using tools to enable a person to get control on some subconscious body processes by making them perceptible [54]. EMG BFT, which was first introduced in 1979, is considered the most common type of biofeedback used for pelvic floor rehabilitation purposes [55]. BFT help patients to correctly identify and isolate the muscles to enable them to effectively contract them. There are three main approaches in how biofeedback is useful as a part of pelvic floor rehabilitation for FI [37]. The most common one is for strength and endurance training for the pelvic floor and/or anal sphincter. The second treatment modality is to use BFT to improve rectal sensitivity or compliance, allowing the patient to detect smaller volumes of stool at an earlier time, and enabling patients to reach the restroom before accidents occur [56]. The third approach deals with anal sphincter coordination training. Patient is taught to do a voluntary external sphincter contraction to counteract the involuntary relaxation of the internal sphincter [37, 57]. Biofeedback was found more beneficial in patients with urgency FI, post sphincteroplasty, or anal repair. However, severe FI, pudendal neuropathy, and underlying neurological problems have been associated with worse outcomes [37].

Electrical stimulation

Electrical stimulation targeting the external anal sphincter is another modality that has been proposed for the rehabilitative treatment of FI. Electrical stimulation has been shown to transform fast-twitch muscle fibers to slow-twitch muscle fibers, thus improving endurance [58]. It also increases capillary density, allowing more blood flow to the oxidative slow-twitch fibers [59]. Electrical stimulations can be delivered to the pelvic floor and anal sphincter in different ways, as surface electrodes or intrarectal probes [60]. A study held by Schwandner group reported that patients with sphincter damage and neuropathic anal incontinence responded better to a combination treatment termed triple target treatment or 3 T, which consisted of amplitude modulated-medium frequency (AM-MF) stimulation, EMG-triggered AM-MF stimulation, and EMG biofeedback training, than to EMG biofeedback alone [61].

Percutaneous tibial nerve stimulation (PTNS)

PTNS is a minimally invasive outpatient technique with almost no associated morbidity and a success rate of up to 60%. PTNS takes place through inserting a 34-gauge needle electrode (or surface electrode) to stimulate the posterior tibial nerve near the medial malleolus to achieve effects via L4–S3 nerve roots. It was initially used in treatment of overactive bladder, and it is now gaining ground as a treatment for FI [62].

Sacral nerve stimulation (SNS)

SNS was first introduced as a minimally invasive surgical option for refractory FI in 1995 in Europe in cases of conservative treatments failure. FDA approved this technique in the USA in April 2011 [45, 63]. SNS uses electrical stimulation of the sacral nerves, thus modulating the lower bowel, anal sphincter, and pelvic floor [64]. Patients usually undertake a test stimulation period. Patients who show significant benefit, at least a 50% reduction in FI episodes, undergo implantation of the definitive pulse generator [65].

Injectables

Injection of a bulking agent into the submucosal or intersphincteric space to augment the closure of the proximal anal canal was first introduced in 1993 [66]. It is considered a simple and a minimally invasive technique. According to the American Society of Colon and Rectal Surgeons practice, this method is most beneficial when FI is primarily due to internal anal sphincter dysfunction; however, its long-term efficacy and definite protocol have yet to be defined [67].

Secca® procedure

The Secca® procedure, an application of a temperature-controlled radiofrequency (RF) energy to the IAS in order to induce collagen deposition causing tightening of the sphincter, was approved by the FDA for treatment of refractory FI in 2002 [68].

Although conservative treatment of FI is effective in more than half of all patients, a proportion with persistent severe incontinence require more intensive treatment and direct surgical interventions which are beyond the scope of this article.

Conclusion

Finally, management of FI is a true challenge that needs multidisciplinary approach. Integrated diagnostic work-up between the related subspecialities, as well as tailoring the management plan according to each case, would help to reach best outcome.

Availability of data and materials

Not applicable.

Abbreviations

AM-MF:

Amplitude modulated-medium frequency

BFT:

Biofeedback training

CRD:

Complex repetitive discharge

DSEPs:

Dermatomal somatosensory-evoked potentials

EAS:

External anal sphincter

EDX:

Electrodiagnostic

EMG:

Electromyography

FDA:

Food and Drug Administration

FI:

Fecal incontinence

IAS:

Internal anal sphincter

IBD:

Inflammatory bowel disease

MRI:

Magnetic resonant imaging

MSA:

Multiple system atrophy

MUAP:

Motor unit action potential

MUP:

Motor unit potential

NCS:

Nerve conduction study

PFMT:

Biofeedback-guided pelvic floor muscle training

PFR:

Pelvic floor rehabilitation

PNTML:

Pudendal nerve terminal motor latency

PSEPs:

Pudendal somatosensory-evoked potentials

PTNS:

Peripheral tibial nerve stimulation

QEMG:

Quantitative electromyography

RF:

Radiofrequency

SEP:

Somatosensory-evoked potentials

SNS:

Sacral nerve stimulation

SSR:

Sympathetic skin response

References

  1. Grossi U, De Simone V, Parello A et al (2019) Gatekeeper improves voluntary contractility in patients with fecal incontinence. Surg Innov 26(3):321–327

    Article  PubMed  Google Scholar 

  2. Arbuckle JL, Parden AM, Hoover K et al (2019) Prevalence and awareness of pelvic floor disorders in female adolescents seeking gynecologic care. J Pediatr Adolesc Gynecol 32(3):288–292

    Article  PubMed  Google Scholar 

  3. Thubert T, Cardaillac C, Fritel X et al (2018) Definition, epidemiology and risk factors of obstetric anal sphincter injuries: CNGOF perineal prevention and protection in obstetrics guidelines. Gynecol Obstet Fertil Senol 46(12):913–921

    CAS  PubMed  Google Scholar 

  4. Bassotti G, Crowell MD, Whitehead WE (1993) Contractile activity of the human colon: lessons from 24 hour studies. Gut 34(1):129–133

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bharucha AE, Klingele CJ (2005) Autonomic and somatic systems to the anorectum and pelvic floor. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy, 4th edn. Elsevier Saunders, Philadelphia, pp 279–298

    Chapter  Google Scholar 

  6. Stokes WE, Jayne DG, Alazmani A et al (2019) A biomechanical model of the human defecatory system to investigate mechanisms of continence. Proc Inst Mech Eng H 233(1):114–126

    Article  PubMed  Google Scholar 

  7. Rajindrajith S, Devanarayana NM, Benninga M (2013) Review article: faecal incontinence in children: epidemiology, pathophysiology, clinical evaluation and management. Aliment Pharmacol Ther 37(1):37–48

    Article  CAS  PubMed  Google Scholar 

  8. Kitaguchi D, Nishizawa Y, Sasaki T et al (2019) Clinical benefit of high resolution anorectal manometry for the evaluation of anal function after intersphincteric resection. Colorectal Dis 21(3):335–341

    Article  CAS  PubMed  Google Scholar 

  9. Vande Velde S, Van Renterghem K, Van Winkel M et al (2018) Constipation and fecal incontinence in children with cerebral palsy. Overview of literature and flowchart for a stepwise approach. Acta Gastroenterol Belg. 81(3):415–418

    CAS  PubMed  Google Scholar 

  10. Quezada Y, Whiteside JL, Rice T et al (2015) Does preoperative anal physiology testing or ultrasonography predict clinical outcome with sacral neuromodulation for fecal incontinence? Int Urogynecol J 26:1613–1617

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lero AM. Electrophysiological study of the pelvic floor. Springer International Publishing Switzerland 2017 C. Ratto et al. (eds.), Colon, Rectum and Anus: Anatomic, Physiologic and Diagnostic Bases for Disease Management, Coloproctology 1, DOI https://doi.org/10.1007/978-3-319-09807-4_24

  12. Beersiek F, Parks AG, Swash M (1979) Pathogenesis of ano-rectal incontinence. A histometric study of the anal sphincter musculature. J Neurol Sci. 42:111–127

    Article  CAS  PubMed  Google Scholar 

  13. Weledji EP (2017) Electrophysiological Basis of Fecal Incontinence and Its Implications for Treatment. Ann Coloproctol 33(5):161–168

    Article  PubMed  PubMed Central  Google Scholar 

  14. Olsen AL, Ross M, Stansfield RB et al (2003) Pelvic floor nerve conduction studies: establishing clinically relevant normative data. Am J Obstet Gynecol 189:1114–1119

    Article  PubMed  Google Scholar 

  15. Podnar S, Vodušek DB (2001) Standardization of anal sphincter electromyography: utility of motor unit potential parameters. Muscle Nerve. 24(7):946–951. https://doi.org/10.1002/mus.1093

    Article  CAS  PubMed  Google Scholar 

  16. Bianchi F, Maddalena G, Osio M et al (2017) Neurophysiology of the pelvic floor in clinical practice: a systematic literature review. Funct Neurol 32(4):173–193

    Article  Google Scholar 

  17. Kenton K (2005) Pelvic floor neurophysiology: an AANEM Workshop

    Google Scholar 

  18. Zhao L, Du H, Li B, Wu S, Lin N, Cui L (2014) The impact of physiological features on external anal sphincter electromyography. J Neurol Neurophysiol 5:5

    Google Scholar 

  19. Snooks SJ, Barnes PR, Swash M (1984) Damage to the innervation of the voluntary anal and periurethral sphincter musculature in incontinence: an electrophysiological study. J Neurol Neurosurg Psychiatry 47:1269–1273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Snooks SJ, Swash M, Henry MM (1985) Abnormalities in central and peripheral nerve conduction in patients with anorectal incontinence. J R Soc Med 78:294–300

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Fowler CJ (ed) (1999) Neurology of bladder, bowel, and sexual dysfunction. Butterworth-Heinemann, Boston, MA, Oxford

    Google Scholar 

  22. Pelliccioni G, Pelliccioni P. Neurophysiology and neurophysiological evaluation of the pelvic floor. Springer International Publishing Switzerland 2015 43 J. Martellucci (ed.), Electrical Stimulation for Pelvic Floor Disorders

  23. Chen AS, Luchtefeld MA, Senagore AJ et al (1998) Pudendal nerve latency. Does it predict outcome of anal sphincter repair? Dis Col Rect 41:1005–1009

    Article  CAS  Google Scholar 

  24. Rosato GO, Lumi CM, Neurophysiology in pelvic floor disorders. In: Complex Anorectal Disorders. Springer, London. https://doi.org/10.1007/1-84628-057-5_11

  25. Podnar S (2004) Criteria for neuropathic abnormality in quantitative anal sphincter electromyography. Muscle Nerve 30:547–687

    Article  Google Scholar 

  26. Podnar S, Vodusek DB, Stalberg E (2002) Comparison of quantitative techniques in anal sphincter electromyography. Muscle Nerve 25:83–92

    Article  PubMed  Google Scholar 

  27. Gadallah N, Reda M, Fayez, Ghanima I (2008) Associated sphincter neurogenic defect as a predictor of postoperative fecal incontinence in patients with Hirschsprung’s disease. Neurourol Urodyn 27(7). https://onlinelibrary.wiley.com/toc/15206777/2008/27/7, https://www.ics.org/2008/abstract/78

  28. Ferrara A, Lujan JH, Cebrian J et al (2001) Clinical, manometric, and EMG characteristics of patients with fecal incontinence. Tech Coloproctol 5(1):13–18

    Article  CAS  PubMed  Google Scholar 

  29. Podnar S (2014) Utility of sphincter electromyography and sacral reflex studies in women with cauda equina lesions. Neurourol Urodyn 33(4):426–430

    Article  PubMed  Google Scholar 

  30. Yeh M, Yamada T, Kimura J (2006) Chapter 20 Applications of SSEP recordings in the evaluation of the peripheral nervous system. In: Kimura J (ed) Handbook of Clinical Neurophysiology, vol 7. Elsevier, Amsterdam, pp 443–466

    Chapter  Google Scholar 

  31. Benson JT, 1996,: Clinical neurophysiologic techniques in incontinence, in Ostergard DR, Bent AE: Urogynacology and Urodynamics. Baltimore, Williams Wilkins, 239

  32. Rapidi CA, Karandreas N, Katsifotis C et al (2006) A combined urodynamic and electrophysiological study of diabetic cystopathy. Neurourol Urodyn 25(1):32–38

    Article  PubMed  Google Scholar 

  33. Malladi P, Simeoni S, Panicke JN (2020) The role of pelvic neurophysiology testing in the assessment of patients with voiding dysfunction. Curr Bladder Dysfunct Rep 15:229–239

    Article  Google Scholar 

  34. Dole VP, Thaysen JH (1953) Variation in the functional power of human sweat glands. J Exp Med 98(2):129–144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Tan JJ, Chan M, Tjandra JJ (2007) Evolving therapy for fecal incontinence. Dis Colon Rectum 50(11):1950–1967

    Article  PubMed  Google Scholar 

  36. van BlusséOud-Alblas M, Thomeer BJ, Stam HJ et al (2008) Fecal incontinence: an update on available techniques in diagnosis and treatment. Surg Technol Int 17:156–164

    Google Scholar 

  37. Norton C, Cody JD (2012) Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev 7:CD002111

    Google Scholar 

  38. Santoro GA, Wieczorek AP, Bartram CI (2010) Pelvic floor disorders: imaging and multidisciplinary approach to management. Springer-Verlag Italia, Milan, p 317

    Book  Google Scholar 

  39. Norton C, Chelvanayagam S (2001) Methodology of biofeedback for adults with fecal incontinence: a program of care. JWound Ostomy Continence Nurs 28(3):156–168

    CAS  Google Scholar 

  40. Hansen JL, Bliss DZ, Peden C (2006) Diet strategies used by women to manage fecal incontinence. J Wound Ostomy Continence Nurs 33(1):52–61 (discussion 61–62)

    Article  PubMed  Google Scholar 

  41. Bliss DZ, Jung HJ, Savik K et al (2001) Supplementation with dietary fiber improves fecal incontinence. Nurs Res 50(4):203–213

    Article  CAS  PubMed  Google Scholar 

  42. Ehrenpreis ED, Chang D, Eichenwald E (2006) Pharmacotherapy for fecal incontinence: Review. Dis Colon Rectum 50:641–649

    Article  Google Scholar 

  43. Stokes G (2002) Psychological approaches to bowel care in older people with dementia. In: Potter J, Norton C, Cottenden A (eds) Bowel Care in Older People. Royal College of Physicians, London, pp 97–109

    Google Scholar 

  44. Townsend MK, Matthews CA, Whitehead WE et al (2013) Risk factors for fecal incontinence in older women. Am J Gastroenterol 108(1):113–119

    Article  PubMed  Google Scholar 

  45. Rao SSC (2004) American College of Gastroenterology Practice Parameters Committee. Diagnosis and management of fecal incontinence. Am J Gastroenterol 99(8):1585–1604. https://doi.org/10.1111/j.1572-0241.2004.40105.x

  46. Costilla VC, Foxx-Orenstein AE, Mayer AP et al (2013) Office-based management of fecal incontinence. Gastroenterol Hepatol 9(7):423–433

    Google Scholar 

  47. Wang JY, Abbas MA (2013) Current management of fecal incontinence. Perm J 17(3):65–73

    Article  PubMed  PubMed Central  Google Scholar 

  48. Omar MI, Alexander CE (2013) Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev. 6:CD002116

    Google Scholar 

  49. Bo K, Berghmans B, Morkved S (eds) (2007) Evidence-based physical therapy for the pelvic floor: bridging science and clinical practice. Edinburgh, Elsevier Ltd, pp 171–178

    Google Scholar 

  50. Engel BT, Nikoomanesh P, Schuster MM (1974) Operant conditioning of rectosphincteric responses in the treatment of fecal incontinence. N Engl J Med 290(12):646–649

    Article  CAS  PubMed  Google Scholar 

  51. Bartlett L, Sloots K, Nowak M et al (2011) Biofeedback for fecal incontinence: a randomized study comparing exercise regimens. Dis Colon Rectum 54(7):846–856

    Article  PubMed  Google Scholar 

  52. Norton C, Chelvanayagam S, Wilson-Barnett J et al (2003) Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology 125(5):1320–1329

    Article  PubMed  Google Scholar 

  53. Solomon MJ, Pager CK, Rex J et al (2003) Randomized, controlled trial of biofeedback with anal manometry, transanal ultrasound, or pelvic floor retraining with digital guidance alone in the treatment of mild to moderate fecal incontinence. Dis Colon Rectum 46(6):703–710

    Article  PubMed  Google Scholar 

  54. Norton C, Chelvanayagam S. Conservative management of faecal incontinence in adults. In: Norton C, Chelvanayagam S. Bowel Continence Nursing. UK: Beaconsfield Publishers LTD; 2004.

  55. MacLeod JH (1979) Biofeedback in the management of partial anal incontinence: a preliminary report. Dis Colon Rectum 22(3):169–171

    Article  CAS  PubMed  Google Scholar 

  56. Chiarioni G, Whitehead WE (2008) The role of biofeedback in the treatment of gastrointestinal disorders. Nat Clin Pract Gastroenterol Hepatol 5(7):371–382

    Article  PubMed  Google Scholar 

  57. Whitehead WE, Orr WC, Engel BT et al (1982) External anal sphincter response to rectal distention: learned response or reflex. Psychophysiology 19(1):57–62

    Article  CAS  PubMed  Google Scholar 

  58. Salmons S, Vrbová G (1969) The influence of activity on some contractile characteristics of mammalian fast and slow muscles. J Physiol 201(3):535–549

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Hudlická O, Dodd L, Renkin EM et al (1982) Early changes in fiber profile and capillary density in long-termstimulated muscles. Am J Physiol 243(4):H528–H535

    PubMed  Google Scholar 

  60. Schwandner T, Heimerl T, König IR et al (2012) 3T-AI: a new treatment algorithm for anal incontinence with a higher evidence level [in German]. Zentralbl Chir 137(4):345–351

    CAS  PubMed  Google Scholar 

  61. Schwandner T, König IR, Heimerl T et al (2010) Triple target treatment (3T) is more effective than biofeedback alone for anal incontinence: the 3T-AI study. Dis Colon Rectum 53(7):1007–1016

    Article  PubMed  Google Scholar 

  62. Boyle DJ, Prosser K, Allison ME et al (2010) Percutaneous tibial nerve stimulation for the treatment of urge fecal incontinence. Dis Colon Rectum 53(4):432–437

    Article  PubMed  Google Scholar 

  63. Matzel KE (2011) Sacral nerve stimulation for faecal incontinence: its role in the treatment algorithm. Colorectal Dis 13(Suppl. 2):10–14

    Article  PubMed  Google Scholar 

  64. Kenefick NJ (2006) Sacral nerve neuromodulation for the treatment of lower bowel motility disorders. Ann R Coll Surg Engl 88(7):617–623

    Article  PubMed  PubMed Central  Google Scholar 

  65. Mowatt G, Glazener C, Jarrett M (2008) Sacral nerve stimulation for fecal incontinence and constipation in adults: a short version Cochrane review. Neurourol Urodynam 27:155–161

    Article  CAS  Google Scholar 

  66. Graf W, Mellgren A, Matzel KE et al (2011) Efficacy of dextranomer in stabilized hyaluronic acid for treatment of faecal incontinence: a randomized, sham-controlled trial. Lancet 377:997–1003

    Article  CAS  PubMed  Google Scholar 

  67. Watson NFS, Koshy A, Sagar PM (2012) Anal bulking agents for faecal incontinence. Colorectal Dis 14(suppl 3):29–33

    Article  PubMed  Google Scholar 

  68. Parisien CJ, Corman ML (2005) The Secca procedure for the treatment of fecal incontinence: definitive therapy or short-term solution. Clin Colon Rectal Surg 18(1):42–45

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We are grateful to all the authors of the previous researches used in this manuscript.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

Each one of the authors was responsible for a topic in the manuscript as regards data collection, editing, and writing. We confirm that our manuscript has not been published before and is not under consideration for publication as a full article elsewhere.

Corresponding author

Correspondence to Abeer K. El Zohiery.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The other authors declare that they have no competing interests. Naglaa Ali Gadallah and Abeer El Zohiery are in the editorial board.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gadallah, N.A., Zohiery, A.K.E., Gergius, Y.S. et al. Fecal incontinence: challenges in electrodiagnosis and rehabilitation. Egypt Rheumatol Rehabil 50, 65 (2023). https://doi.org/10.1186/s43166-023-00229-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43166-023-00229-2

Keywords